Cephalon abandons ship on Nuvigil jet lag indication
This article was originally published in Scrip
Executive Summary
Cephalon has thrown in the towel in trying to get the US FDA's blessing to market the company's narcolepsy drug Nuvigil (armodafinil) as a jet lag treatment.